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Abstract
We investigate the interaction of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide
(CNP) with their receptors (NPRA, NPRB and NPRC), as well as the proportion and localization of those receptors in the rat
ciliary body. Binding assays and affinity cross-linking experiments demonstrated the presence of the NPRC receptor type.
However, the three natriuretic peptides stimulate the guanylate cyclase activity in the ciliary body membranes suggesting the
presence of the NPRA and NPRB receptor type. Microautoradiographic data show that the NPRs are localized in the whole
ciliary body. Our results indicated that NPRC is the most prominent receptor type in this tissue. © 1998 Elsevier Science Ltd. All
rights reserved.
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1. Introduction
The natriuretic peptide family is composed of at least
three ligands: atrial natriuretic peptide (ANP), brain
natriuretic peptide (BNP) and C-type natriuretic pep-
tide (CNP). ANP and BNP regulate body fluid
homeostasis and blood pressure [1,2]. CNP acts mainly
as a vasodilator with little natriuretic activity, and is
found principally in the central nervous system and
endothelial cells [3,4].
The natriuretic peptides can stimulate the production
of cGMP through the activation of specific receptors:
the type A natriuretic peptide receptor (NPRA) and the
type B natriuretic peptide receptor (NPRB). These re-
ceptors are membrane-bound insoluble guanylyl cy-
clases with molecular sizes of 120–140 kDa [5]. The
NPRA receptor selectively responds to ANP and, to a
lesser extent, to BNP [6], whereas NPRB is selectively
activated by CNP and, in a lesser degree, by ANP and
BNP [7]. The third natriuretic peptide receptor, NPRC,
which is composed of two identical subunits with the
molecular size of 60–70 kDa held together by disulfide
bonds, is known to have its major role in the clearance
of natriuretic peptides from blood circulation [8]. The
NPRC receptor has no intrinsic ability to generate
cGMP although it mediates changes in cAMP [9,10]
and phosphoinositides [11]. It binds the three natri-
uretic peptides with approximately equal affinity, as
well as ring-deleted and truncated linear peptides
[4,7,12]. The five amino acid, ring-deleted ANP
analog,(des (Gln18Ser19Gly20Leu21Gly22) rANF-(3-23)-
NH2), named C-ANP, has been reported to be specific
for the NPRC receptor [8,13], even though it interacts
with NPRA and NPRB receptors at high concentra-
tions (\1 mM) [14]. This peptide has been used to
distinguish and quantify NPRC receptors [4,14].
In the eye, it has been described that ANF increases
cGMP production in the rabbit ciliary processes [15,16],
and that BNP increases the concentration of cGMP in
the aqueous humour of the rabbit eye [17]. These
results predict the existence of natriuretic peptide recep-
tors in the eye. Indeed, Bianchi et al. [18] identified
ANP binding sites in rabbit and rat ciliary processes by
binding assay and autoradiography. Binding sites for
125I-ANF have also been found in rat retina [19]. Re-
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cently, specific high affinity binding sites for 125I-
[Tyr0]-CNP have been identified in human trabecular
meshwork cells and ciliary muscle cells [20]. These
data, together with the observations that the natri-
uretic peptides can decrease the intraocular pressure
(IOP) [15–17,21,22] and alter ciliary blood flow [23],
suggest that the peptides may act on specific receptors
to control IOP. In addition, Ferna´ndez-Durango et
al. [24] reported that messenger RNAs encoding the
natriuretic peptides and their receptors are expressed
in the eye. Thus, the eye appears to be able to syn-
thesize all the components of the natriuretic peptide
system necessary to modulate IOP independently of
changes in the plasma concentration of these peptides.
The interaction of the three ligands, ANP, BNP,
CNP with their three types of receptors to produce
biological effects in the ciliary body is unknown. Fur-
thermore, the proportion of the three natriuretic pep-
tide receptors and their localization in the ciliary
body remain to be elucidated. For these reasons, we
studied in the rat ciliary body: (1) the characteriza-
tion of ANP, BNP and CNP specific binding sites
and their proportions by binding assay and affinity
cross-linking; (2) the existence of particulate guanylate
cyclase activity and its activation by ANP, BNP and
CNP; and (3) the localization of the specific binding
sites by microautoradiography.
2. Materials and methods
2.1. Materials
Atrial natriuretic peptide (ANP), brain natriuretic
peptide (BNP), C-type natriuretic peptide (CNP), C-
ANP and 125I-[Tyr0]-CNP (1627 Ci:mmol) were ob-
tained from Peninsula Laboratories (Merseyside, UK).
125I-ANP (2000 Ci:mmol), 125I-BNP (2000 Ci:mmol)
and the photographic emulsion (LM1) for microau-
toradiography were obtained from Amersham Inter-
national (Buckinghamshire, UK). Dissuccinimidyl
suberate (DSS) was purchased from Pierce Chemical
Co.(Rockford, IL). Standard proteins for elec-
trophoresis (SDS-PAGE standards LMW) were from
BIO-RAD (Richmond CA). Whatman GF:C filters
were from Whatman International (Maidstone, UK).
Aprotinin, phenylmethylsulphonylfluoride (PMSF),
EDTA, pepstatin, triethanolamine, 3-isobutil-1-
methylxanthine, theophyline, Cl2Mn, GTP, creatinine
phosphokinase, phosphocreatinine, poly-L-lysine,
paraformaldehide and glutaraldehide were obtained
from Sigma (St.Louis, MO). Developer liquid was
purchased from Kodak, and fixative from Ilford
(Cheshire, UK).
2.2. Preparation of ciliary body membranes
Adult male Wistar rats (250–350 g) (n100) were
used in all experiments. The animals were kept in a
temperature-controlled room on a 12 h light:dark cy-
cle and fed ad libitum. Experiments were carried out
in accordance with the European Communities Coun-
cil Directive of 24 November 1986 (86:609:EEC). The
eyes of the rats were removed immediately after de-
capitation. The ciliary bodies were dissected free of
retina and vitreous humour. Ciliary body membranes
were prepared as previously described [19]. Briefly,
ciliary bodies were homogenized on ice in 5 mM
Tris–HCl buffer pH 7.4, containing 0.32 M sucrose,
0.5 mM PMSF, 0.2 mM pepstatin, and 0.8 mM apro-
tinin. The homogenates were centrifuged at 30000g
for 30 min in the same buffer. The pellets were resus-
pended in 50 mM Tris–HCl buffer pH 7.4 at a
protein concentration of 0.75–1 mg:ml. The protein
concentration was estimated by the method of Lowry
et al. [25]. Tissue preparations were stored in aliquots
at 70°C and used within 1 month.
2.3. ANP, BNP, and CNP binding assays
Ciliary body membranes (15–25 mg of protein) were
incubated for 60 min at 25°C in 300 ml (final volume) of
50 mM Tris–HCl buffer pH 7.4 containing 0.5 mM
PMSF, 0.2 mM pepstatin, 0.1% BSA, and 0.03%
bacitracin. In the competitive experiments, the binding
assay was performed with 5–8 pM of 125I-ANP, 125I-BNP
or 125I-[Tyr0]-CNP and varying concentrations of
unlabeled ANP, BNP, CNP or C-ANP (1013 to 107
M). Increasing concentrations of labelled ANP, BNP or
CNP (0.38–80 pM) were used in the saturation
experiments. The specific binding of 125I-ANP, 125I-BNP
and 125I-[Tyr0]-CNP was calculated by subtracting
non-specific binding (125I-ANP bound in the presence of
1 mM ANP, 125I-BNP bound in the presence of 1 mM BNP
and 125I-[Tyr0]-CNP bound in the presence of 1 mM CNP)
from total 125I-ANP, 125I-BNP or 125I-[Tyr0]-CNP
binding (in absence of unlabelled ANP, BNP or CNP).
The binding reaction was terminated by diluting the
reaction mixture with 3 ml of 50 mM Tris–HCl buffer
pH 7.4, followed by rapid vacuum filtration through
Whatman GF:C filters previously soaked for 1h in 0.3%
vol:vol polyethylenimine solution. Each filter was
washed twice with 3 ml of 50 mM Tris–HCl buffer, dried,
and removed for counting on a LKB gamma-counter
with 75% efficiency. Several unrelated peptides, including
somatostatin, endothelin, tyroid stimulating hormone
(TSH), growth hormone (GH) or insulin, at the
concentration of 1 mM, were tested for 125I-ANP,
125I-BNP or 125I-[Tyr0]-CNP binding inhibition under the
same conditions as in the competitive experiments.
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2.4. Affinity cross-linking studies
This study was made as previously described in rat
retina [19]. The labelled peptides (125I-ANP, 125I-BNP or
125I-[Tyr0]-CNP), 35 pM, were incubated with ciliary
body membranes (45 mg of protein) in a total volume of
300 ml of 10 mM Hepes buffer, pH 7.4, containing 0.5
mM PMSF, 0.2 mM pepstatin, 0.1% BSA, and 0.03%
bacitracin, for 60 min at 25°C. The reaction was termi-
nated by centrifugation at 30000g for 15 min at 4°C.
The pellets were resuspended in 10 mM Hepes buffer,
pH 7.4, and labelled peptides were cross-linked on
receptors with 0.5 mM DSS. The reaction was quenched
20 min later with 2 M ammonium acetate. The specific-
ity of the binding was determinated by the addition of
0.1 mM ANP, BNP, CNP or C-ANP to the incubation
mixture. Samples were denatured under reducing (2%
b-mercaptoethanol) and non-reducing conditions prior
to polyacrylamide gel electrophoresis.
2.5. Sodiumdodecylsulfate (SDS)-polyacrylamide gel
electrophoresis
Gel electrophoresis was performed according to the
method of Lammeli [26], using 8% SDS-polyacrylamide
gels. Samples were run for 1 h 45 min at 125 V. After
electrophoresis, proteins were visualised by Coomassie
blue staining; the gels were then dried and exposed to a
X-OMAT RP6 Kodak film with intensifying screen at
70°C.
2.6. Guanylate cyclase acti6ity
Natriuretic peptides-activated guanylate cyclase activ-
ity was measured as the rate of conversion of GTP to
cyclic GMP as previously described by Inagami et al.
[27]. For this assay, reaction tubes were prepared to
contain (in 0.1 ml final volume): Tris–HCl 50 mM, pH
7.4; 50 mM triethanolamine, 2 mM 3-isobutil-1-
methylxanthine, 10 mM theophyline, 3 mM Cl2Mn, 1
mM GTP, 75 U:ml creatinine phosphokinase, 72 mM
phosphocreatinine, 0.1 mM natriuretic peptides and
ciliary body membranes (6 mg of protein). The reaction
was started by the addition of GTP. The tubes were
incubated for 30 min. at 37°C, and the reaction was
stopped by addition of 2 ml 30 mM EDTA at 80°C,
followed by boiling for 3 min. The cyclic GMP formed
was subsequently measured by specific radioim-
munoassay (Amersham RPA 525) using a non acetyla-
tion protocol. The minimal detectable limit of cGMP by
this assay was 50 fmol:tube.
2.7. Microautoradiography of 125I-ANP and
125I-[Tyr0]-CNP binding
The eyes of the rats, removed immediately after
decapitation, were immersed in 2-methylbutane on liq-
uid nitrogen. Sections (12 mm) were cut in a cryostat at
28°C, thaw-mounted onto poly-L-lysine treated slides,
and dried for 4 h in a desiccator under vacuum at 4°C.
The sections were then preincubated in 50 mM Tris–
HCl buffer pH 7.4 containing 100 mM NaCl, 5 mM
ClMg2, 0.5 mM PMSF, 2 mM pepstatin, 10.000 U.I.C.
aprotinin, and 0.5% BSA for 15 min. at 25°C. Sections
were then incubated with 40 pM 125I-ANP or 125I-[Tyr0]-
CNP in the same buffer for 60 min at room temperature.
Specific binding was determined by radioligand displace-
ment with 0.1 mM ANP, BNP, CNP or C-ANP. After
incubation, the slides containing the sections were
washed three times with fresh buffer for 4 min, then
rinsed in fresh bidistillated water and fixed in 4%
paraformaldehyde and 1% glutaraldehyde in 100 mM
phosphate buffer for 4 h. The sections were covered with
LM1 Amersham emulsion, stored in the dark at 4°C for
10 days and developed with Kodak D19 developer.
2.8. Data analysis
The binding data for the determination of the
density and affinity of binding sites were evaluated by
computer-assisted non-linear regression analysis with
the LIGAND program [28], after preliminary
treatment of data with the EBDA program [29] The
inhibition constant (ki) was calculated according to
the method of Cheng and Prusoff [30]. The values are
presented as means9SEM. The curves were plotted
using the SigmaPlot Scientific Graphing System
(version 4.10) computer program by Jandel
Corporation
3. Results
3.1. Saturation studies
Specific 125I-ANP and 125I-BNP binding to rat
ciliary body membranes was saturable in a
concentration-dependent manner. Scatchard analysis
of saturation binding data of 125I-ANP and 125I-BNP
indicated the presence of a single class of high-affinity
binding sites. KD and Bmax values evaluated from
125I-ANP saturation binding data by non-linear
regression analysis were 12.392.9 pM and 198946
fmol:mg of protein (n3), respectively (Fig. 1), and
the Hill coefficient was 0.9490.03 (n4). KD and
Bmax values calculated from 125I-BNP saturation
binding data by the same method were 27912 pM
and 238954 fmol:mg of protein (n4), respectively
(Fig. 1), and the Hill coefficient was 1.01690.01
(n4).
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3.2. Competition studies
Competitive binding experiments were performed us-
ing 5–8 pM 125I-ANP, 125I-BNP or 125I-[Tyr0]-CNP as
labeled hormones. Unlabeled ANP, BNP, CNP and
C-ANP competed for labeled hormones specific binding
sites in a dose-dependent manner (Fig. 2). Analysis of
the competition curves showed that ANP, BNP and
CNP competed with 125I-ANP, 125I-BNP and 125I-
[Tyr0]-CNP with similar affinity (Tables 1 and 2). On
the other hand, C-ANP displaced 100% of 125I-ANP
and 125I-[Tyr0]-CNP binding. These results suggest the
presence of NPRC receptors, without confirming the
presence of guanylate cyclase-coupled receptors (NPRA
or NPRB).
3.3. Cross-linking
125I-ANP, 125I-BNP and 125I-[Tyr0]-CNP (35 pM)
were used to identify the apparent molecular weight of
the natriuretic receptors in rat ciliary body membranes.
Affinity labeling of these membranes by cross-linking
with 125I-ANP (Fig. 3(A)), 125I-BNP (Fig. 3(B)) and
125I-[Tyr0]-CNP (Fig. 3(B)), using disuccinimidyl suber-
ate (DSS), indicated the presence of two specific bands
with molecular weights of :140 and 66 kDa (Fig.
3(A), lane 1; Fig. 3(B), lanes 1 and 5). The labeling of
these binding proteins was specifically inhibited by the
presence of excess nonradioactive ANP (Fig. 3(A), lane
2;Fig. 3(B), lanes 2 and 6), BNP (Fig. 3, lanes 3) or
CNP lanes (Fig. 3(A), lane 5; Fig. 3(B), lane 7) (0.1
mM) indicating that the labeling of the two bands was
specific. In the presence of 0.1 mM C-ANP (Fig. 3(A),
lane 4; Fig. 3(B), lanes 4 and 8) the labeling was also
specifically inhibited.
The :140 kDa radiolabeled protein migrated in the
gel to the 66 kDa position when similar experiments
were performed with 125I-ANP and 125I-[Tyr0]-CNP un-
der reducing conditions (2% b-mercaptoethanol) (Fig.
3(C)). These results suggest the unique presence of
NPRC receptors.
3.4. Microautoradiography
Specific binding of 125I-ANP and 125I-[Tyr0]-CNP was
observed in the rat ciliary body. The silver grains are
localized in pigmented and non-pigmented epithelium
and in vascular stroma. These results are shown in Fig.
4(A) (total binding of 125I-ANP) and Fig. 5(A) (total
binding of 125I-[Tyr0]-CNP). These figures represent
dark-field photomicrographs. Their correspondent
bright-field photomicrographs of rat ciliary body
stained with toluidine blue are shown in Fig. 4(B) and
Fig. 5(B), respectively. The unlabeled peptides ANP,
BNP, CNP and C-ANP completely displaced the 125I-
ANP (Fig. 4(C, D, E and F)) as well as the 125I-[Tyr0]-
CNP (Fig. 5(C, D, E and F)).
3.5. Guanylate cyclase acti6ity
In the rat ciliary body membranes, the baseline val-
ues of guanylate cyclase activity were 64.691.7 pmol:
mg protein per min. In the presence of 107 M ANP,
107 M BNP (specific for NPRA receptor) or 107 M
CNP (specific for NPRB receptor) the values were
82.898.9 pmol:mg protein per min, 80.397.1 pmol:
mg protein:min and 88.799.5 pmol:mg protein per
min, respectively, showing a statistically significant in-
crease (PB0.05, n4) in cGMP production over base-
line (Fig. 6).
4. Discussion
This study demonstrates the existence of high-affinity
binding sites for ANP, BNP and CNP in the rat ciliary
body, and that those peptides stimulate guanylyl cy-
clase activity in this tissue.
Scatchard analysis derived from saturation binding
data revealed one high-affinity binding site for ANP
and BNP. The KD obtained using 125I-ANP and 125I-
BNP were 12.392.9 pM and 27912, respectively. The
Bmax values obtained for 125I-ANP was 198946 fmol:
mg protein, and 238954 fmol:mg protein for 125I-
BNP. These results suggest a single class of receptors,
Fig. 1. (A) Saturacion of specific binding of 125I-ANP () and
125I-BNP () to rat ciliary body membranes. (B) Scatchard transfor-
mation of the specific binding of 125I-ANP () and 125I-BNP ()
from A. Data points are means of duplicate measurements in a
representative experiment.
F.J. Moya et al. : Vision Research 38 (1998) 3833–3841 3837
Fig. 2. Competitive inhibition of 125I-ANP (A), 125I-BNP (B) and 125I-[Tyr0]-CNP (C) binding to rat ciliary body membranes by unlabeled ANP
(), BNP (), CNP () and C-ANP (). The specific binding of labeled peptides in absence of competitor was normalized to 100% (Bo). The
results (B:Bo) are expressed as the percentage of labeled peptides binding in the presence of competitor. Data points are means9SEM of four
independent experiments performed in duplicated.
multiple receptors with similar affinities, or an abun-
dance of one receptor over another. The KD values that
we obtained were similar to those obtained in rabbit
ciliary process [18] and hog ciliary body [31].
Analysis of the competition binding experiments
showed that the rat ciliary body has a single class of
high-affinity binding sites for ANP, BNP and CNP,
and that unlabeled ANP, BNP, CNP and C-ANP dis-
placed the total binding of 125I-ANP, 125I-BNP and
125I-[Tyr0]-CNP to the ciliary body membranes. These
data also suggest the unique presence of the NPRC
receptor or a great abundance of NPRC receptor over
NPRA and NPRB receptors. As Ferna´ndez-Durango et
al. [24] have reported that the messenger RNAs encod-
ing the three natriuretic peptide receptors are expressed
in rat and rabbit ciliary bodies, our results could be
explained as indicating that the majority of natriuretic
receptors in the rat ciliary body belongs to the NPRC
type.
Affinity cross-linking of 125I-ANP, 125I-BNP and 125I-
[Tyr0]-CNP to rat ciliary body membranes resulted in
two specific bands with approximate molecular masses
of :140 and 66 kDa. Both bands were totally dis-
placed by unlabeled ANP, BNP, CNP and C-ANP.
However, under reducing conditions, we only observed
a single band of :66 kDa, which corresponds to the
molecular weight of the non-guanylate cyclase linked
receptor (NPRC receptor). These results, in agreement
with the data obtained using the binding assay, indicate
that either there are fewer of the guanylate cyclase-cou-
pled receptors (NPRA and NPRB), or the efficiency of
cross-linking to these receptors is diminished. Since we
F.J. Moya et al. : Vision Research 38 (1998) 3833–38413838
Table 1
Ki (pM) values for ANP, BNP, CNP and C-ANP in competing for
125I-ANP, 125I-BNP and 125I-[Tyr0]-CNP binding to rat ciliary body
membranes
Unlabeled ligandsLabeled peptides Ki pM
2896ANP
BNP 2995
CNP125I-ANP 2495
24609500C-ANP
9093ANP
BNP125I-BNP 59912
C-ANP 11779373
2094ANP
125I-[Tyr0]-CNP BNP 80919
2396CNP
11459215C-ANP
The data presented are the mean9S.E.M. of four determinations
performed in duplicate. The Ki was calculated according to the
formula of [30].
Fig. 3. (A) and (B), Autoradiogram of 125I-ANP ((A), lanes 1 to 5),
125I-BNP ((B), lanes 1 to 4) and 125I-[Tyr0]-CNP (B. lanes 5 to 8)
cross-linked to natriuretic peptide receptors on rat ciliary body mem-
branes. Membranes were incubated with labeled peptides in absence
((A), lane 1; (B) lanes 1 and 5) or presence of 0.1 mM ANP ((A), lane
2; (B) lanes 2 and 7), 0.1 mM BNP ((A) and (B), lane 3), 0.1 mM
C-ANP ((A), lane 4; (B). lanes 4 and 8), and 0.1 mM CNP ((A), lane
5; (C), lane 6). (C): Autoradiogram of 125I-ANP ((C). lanes 1 to 4)
and 125I-[Tyr0]-CNP ((C), lanes 5 to 8), under reducing conditions
((C), lanes 3, 4, 7 and 8) in absence ((C), lanes 1, 3, 5 and 7) or
presence of 0.1 mM ANP ((C), lanes 2 and 4) or 0.1 mM CNP ((C),
lanes 6 and 8).
have previously cross-linked both receptor types simul-
taneously using the same methodology in rat retina
[19], these data again indicate that there is a low
number of guanylyl cyclase-coupled receptors relative
to NPRC receptors. Similar data have been reported
with ANP on hog ciliary body [31]. On the other hand,
Leitman et al. [32] suggest that three molecular forms
of ANP binding sites may exist (1) a non reducible 130
kDa site (2) a 130 kDa site that is probably comprised
of two identical 66 kDa subunits joined by disulphide
bond and (3) a non-reducible 66 kDa monomer. The
band that we observed of :140 kDa is probably
comprised of two identical 66 KDa subunits joined by
a disulphide bond. The non-reducible 130 kDa band,
associated with guanylate cyclase-coupled receptors, is
absent in our experiments. Thus, our cross-linking ex-
periments indicate the unique presence of NPRC
receptors.
In order to investigate the presence of the guanylate
cyclase-linked receptor types (NPRA and NPRB) in rat
ciliary body membranes, we have examined the effects
of ANP, BNP and CNP on guanylate cyclase activity in
those membranes. Our baseline values of guanylate
cyclase activity were similar to those obtained by
Nathanson [15] in rabbit ciliary bodies. The three natri-
uretic peptides increase the guanylate cyclase activity,
CNP being slightly more potent that ANP and BNP.
Since the NPRA is selectively activated by ANP and
BNP [6], and the NPRB selectively responds to CNP
[7], our results suggest the presence of the functional
receptor types, NPRA and NPRB, in the membrane of
the rat ciliary body. The ciliary body productions of
cGMP induced by ANP, BNP and CNP were similar
and is consistent with the similar KD values obtained in
the binding assay when 125I-ANP, 125I-BNP and 125I-
[Tyr0]-CNP were used as radioligand. In agreement
with our results, Nathanson [15] and Mittag et al. [16]
reported that ANP activates guanylate cyclase in rabbit
ciliary body. The presence of NPRB receptors has also
been demonstrated in human fetal non-pigmented ep-
ithelial cells (NPE) [33].
Our microautoradiography data showed specific
binding of 125I-ANP and 125I-[Tyr0]-CNP in the rat
ciliary body. Silver grains are uniformly distributed in
the ciliary body, and specific binding is totally displaced
in presence of unlabeled natriuretic peptides (107M
Table 2
Receptor density (Bmax) and dissociation constant (KD) values for
ANP, BNP and CNP in competing for 125I-ANP, 125I-BNP and
125I-[Tyr0]-CNP binding to rat ciliary body membranes
125I-BNP125I-ANP 125I-[Tyr0]-CNP
4598 30972895KD (pM)
12391014598 225948Bmax (fmol:mg of
protein)
The data presented are the mean9S.E.M. of four determinations
performed in duplicate. Data were analyzed using the LIGAND
program [28].
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Fig. 4. Dark-field photomicrographs showing the specific 125I-ANP binding sites in rat ciliary body. Cryostat sections were incubated with
125I-ANP in absence (A) or in presence of 0.1 mM unlabeled ANP (C), BNP (D), CNP (E) or C-ANP (F). Bright-field photomicrograph stained
with toluidine blue at similar level (B).
ANP, 107M BNP, 107M CNP and 107M C-
ANP). In contrast with our results, Bianchi et al. [18],
demonstrated by ‘in vivo’ microautoradiography that
the competitive binding sites for 125I-ANP were local-
ized mostly on the pigmented epithelium of the rat
ciliary body. However, the presence of 8% and 7% of
silver grains on non-pigmented epithelium and vascu-
lar stroma, respectively, 2 min after 125I-ANP injec-
tion, led these authors to suggest that binding sites
for 125I-ANP may also be present in these tissues.
This idea was sustained by the fact that silver grains
seem to be progressively internalized at later time in-
tervals after injection of 125I-ANP [18]. In fact,
Tsukara et al. [34], 30 min after the injection of 125I-
ANP observed binding sites on the whole ciliary body
of mice.
From a physiological point of view, the presence of
guanylate cyclase-linked receptors in the ciliary body
suggests an active role for natriuretic peptides in the
regulation of the aqueous humour secretion, and thus
of the IOP. In fact, ANP [15,22,35] and BNP [17]
decrease IOP in various species. In agreement with
this idea, Carre´ and Civan [36] presented evidence
that the cGMP-mediated transmitters ANP and NO
both modulate ion transport across the rabbit ciliary
epithelium. Interestingly Ferna´ndez-Durango et al.
[37] reported than in rabbits with experimental glau-
coma the NPRs are down-regulated in the ciliary
body and that immunoreactive ANP levels in aqueous
humour rise as IOP increases [38].
On the other hand, the great abundance of NPRC
receptors that we found in rat ciliary body was also
observed in specialized endothelial cells composing
the blood-brain barrier [39], suggesting that a high
rate of natriuretic peptides clearance will prevent in-
appropriate fluctuations of the levels of the natriuretic
peptides in these tissues which are specifically sensi-
tive to changes in fluid and electrolyte homeostasis.
In conclusion, in the rat ciliary body the natriuretic
peptides ANP, BNP and CNP stimulate the guanylyl
cyclase activity, probably through the interaction with
NPRA and NPRB receptors. These peptides also bind
to NPRC receptors which are the most prominent
natriuretic receptor types in this tissue. Microautora-
diographic data reveal that NPRs are localized
throughout the whole ciliary body.
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Fig. 5. Dark-field photomicrographs showing the specific 125I-[Tyr0]-CNP binding sites in rat ciliary body. Cryostat sections were incubed with
125I-[Tyr0]-CNP in absence (A) or in presence of 0.1 mM unlabeled ANP (C), BNP (D), CNP (E) or C-ANP (F). Bright-field photomicrograph
stained with toluidine blue at similar level (B).
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